Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Article in The Lancet Regional Health - Americas (June 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in The Lancet Regional Health - Americas (June 2024)